PhenixFIN (PFX) has been beaten down lately with too much selling pressure. While the stock has lost 10.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold ...
PhenixFIN (PFX) has been on a downward spiral lately with significant selling pressure. After declining 12.2% over the past four weeks, the stock looks well positioned for a trend reversal as it is ...
PFX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of PFX shares has decreased $1.11 since the market last closed. This is a 2.67% ...
Zacks Investment Research on MSN
PhenixFIN (PFX) lags Q2 earnings and revenue estimates
PhenixFIN (PFX) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.48 per share a year ago. These figures are ...
PhenixFIN strengthens market attention after announcing a fresh dividend update, highlighting income-focused opportunities ...
Zeus announced the launch of PFX, a breakthrough platform designed to advance catheter innovation with a focus on performance, design flexibility, and sustainability. Zeus also introduced PFX Flex Sub ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results